Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
Rockwell Med (RMTI) Stock Price & Analysis
951 Followers
RMTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $6.24
Previous Close$1.77
Volume178.38K
Average Volume (3M)201.09K
Market Cap
$53.51M
Enterprise Value$56.65M
Total Cash (Recent Filing)$11.73M
Total Debt (Recent Filing)$14.88M
Price to Earnings (P/E)-4.9
Beta2.09
Next Earnings
Aug 12, 2024EPS Estimate
-$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding30,315,684
10 Day Avg. Volume109,943
30 Day Avg. Volume201,085
Standard Deviation0.22
R-Squared0.08
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)5.47
Price to Sales (P/S)0.73
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.93
Enterprise Value/Gross Profit13.90
Enterprise Value/Ebitda-13.17
Forecast
1Y Price Target
$7.00Price Target Upside296.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Rockwell Med News
PremiumCompany Announcements
Rockwell Medical Technologies Unveils Updated Corporate Presentation
PremiumCompany Announcements
Rockwell Medical Unveils Updated Corporate Insight PresentationOwnership Overview
49.83% Insiders
4.62% Mutual Funds
14.88% Other Institutional Investors
30.68% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMTI FAQ
What was Rockwell Medical Technologies’s price range in the past 12 months?
Rockwell Medical Technologies lowest stock price was $1.16 and its highest was $6.24 in the past 12 months.
What is Rockwell Medical Technologies’s market cap?
Currently, no data Available
When is Rockwell Medical Technologies’s upcoming earnings report date?
Rockwell Medical Technologies’s upcoming earnings report date is Aug 12, 2024 which is in 86 days.
How were Rockwell Medical Technologies’s earnings last quarter?
Rockwell Medical Technologies released its earnings results on May 14, 2024. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.04 by -$0.02.
Is Rockwell Medical Technologies overvalued?
According to Wall Street analysts Rockwell Medical Technologies’s price is currently Undervalued.
Does Rockwell Medical Technologies pay dividends?
Rockwell Medical Technologies does not currently pay dividends.
What is Rockwell Medical Technologies’s EPS estimate?
Rockwell Medical Technologies’s EPS estimate is -$0.04.
How many shares outstanding does Rockwell Medical Technologies have?
Rockwell Medical Technologies has 30,315,683 shares outstanding.
What happened to Rockwell Medical Technologies’s price movement after its last earnings report?
Rockwell Medical Technologies reported an EPS of -$0.06 in its last earnings report, missing expectations of -$0.04. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Rockwell Medical Technologies?
Currently, no hedge funds are holding shares in RMTI
---
Rockwell Med Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (296.60% Upside)
$7.00 (296.60% Upside)
Blogger Sentiment
Bullish
RMTI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 4.6%
Last 30 Days ▼ 4.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.92%
12-Months-Change
Fundamentals
Return on Equity
-50.75%
Trailing 12-Months
Asset Growth
25.33%
Trailing 12-Months
Company Description
Rockwell Medical Technologies
Rockwell Medical, Inc. engages in targeting end-stage renal disease and chronic kidney disease. Its dialysis products include hemodialysis concentrates, citrapure, dri-sate, safety data sheets,ancillary products, and renal pure. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
---
RMTI Earnings Call
Q1 2024
0:00 / 0:00
---
RMTI Stock 12 Month Forecast
Average Price Target
$7.00
▲(296.60% Upside)
Technical Analysis
Best Analysts Covering RMTI
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-8.68%
reiterated a buy rating 3 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -8.68% per trade.
---